BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 29258743)

  • 21. Chronic kidney disease and metabolic syndrome as risk factors for cardiovascular disease in a primary care program.
    Greffin S; André MB; Matos JPS; Kang HC; Jorge AJL; Rosa MLG; Lugon JR
    J Bras Nefrol; 2017; 39(3):246-252. PubMed ID: 28902230
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Association between metabolic syndrome and chronic kidney disease and sex specific difference among community elder population in Beijing].
    Liu M; He Y; Wu L; Wang J; Yang S; Wang Y; Zhang D; Zeng J
    Zhonghua Liu Xing Bing Xue Za Zhi; 2015 May; 36(5):411-5. PubMed ID: 26080624
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nocturia, sleep disturbance and the metabolic syndrome.
    Kupelian V
    J Urol; 2012 Dec; 188(6):2041-2. PubMed ID: 23000856
    [No Abstract]   [Full Text] [Related]  

  • 24. Impact of metabolic syndrome on resting energy expenditure in patients with chronic kidney disease.
    Rodrigues CQD; Santos JAP; Quinto BMR; Marrocos MSM; Teixeira AA; Rodrigues CJO; Batista MC
    Clin Nutr ESPEN; 2016 Oct; 15():107-113. PubMed ID: 28531773
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hypertension, chronic kidney disease, and the development of cardiovascular risk: a joint primacy.
    Middleton JP; Pun PH
    Kidney Int; 2010 May; 77(9):753-5. PubMed ID: 20393488
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of metabolic syndrome on postdonation renal function in living kidney donors.
    Yoon YE; Choi KH; Lee KS; Kim KH; Yang SC; Han WK
    Transplant Proc; 2015 Mar; 47(2):290-4. PubMed ID: 25769562
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Disorders of water-electrolyte balance in chronic kidney disease].
    ONEN K
    Turk Tip Cemiy Mecm; 1959 Aug; 25():396-400. PubMed ID: 14428874
    [No Abstract]   [Full Text] [Related]  

  • 28. [The therapy of chronic renal insufficiency and of the uremic syndrome].
    GIGLI G
    Rass Clin Sci; 1961 Nov; 37():297-301. PubMed ID: 13898502
    [No Abstract]   [Full Text] [Related]  

  • 29. Metabolic syndrome and insulin resistance as risk factors for development of chronic kidney disease and rapid decline in renal function in elderly.
    Cheng HT; Huang JW; Chiang CK; Yen CJ; Hung KY; Wu KD
    J Clin Endocrinol Metab; 2012 Apr; 97(4):1268-76. PubMed ID: 22337909
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Contribution of cardiometabolic risk factors to estimated glomerular filtration rate decline in Indigenous Australians with and without albuminuria - the eGFR Follow-up Study.
    Barr EL; Barzi F; Hughes JT; Jerums G; O'Dea K; Brown AD; Ekinci EI; Jones GR; Lawton PD; Sinha A; MacIsaac RJ; Cass A; Maple-Brown LJ
    Nephrology (Carlton); 2018 Jul; 23(7):682-689. PubMed ID: 28503768
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Pediatric chronic kidney disease].
    Pang N
    Zhonghua Er Ke Za Zhi; 2010 May; 48(5):361-4. PubMed ID: 20654038
    [No Abstract]   [Full Text] [Related]  

  • 32. Chronic Kidney Disease in Children: Magnitude of Problem and Challenges.
    Mishra OP; Prasad R
    Indian J Pediatr; 2017 Nov; 84(11):811-812. PubMed ID: 28971319
    [No Abstract]   [Full Text] [Related]  

  • 33. Obesity and obesity-initiated metabolic syndrome: mechanistic links to chronic kidney disease.
    Wahba IM; Mak RH
    Clin J Am Soc Nephrol; 2007 May; 2(3):550-62. PubMed ID: 17699463
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serum uric acid and the risk of cardiovascular and renal disease.
    Borghi C; Rosei EA; Bardin T; Dawson J; Dominiczak A; Kielstein JT; Manolis AJ; Perez-Ruiz F; Mancia G
    J Hypertens; 2015 Sep; 33(9):1729-41; discussion 1741. PubMed ID: 26136207
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chronic Kidney Disease: A Place for Primary Care and Nephrology to Meet.
    Crews DC
    J Gen Intern Med; 2016 Jan; 31(1):5-6. PubMed ID: 26358283
    [No Abstract]   [Full Text] [Related]  

  • 36. [The cutting-edge of medicine; metabolic domino and CKD].
    Itoh H
    Nihon Naika Gakkai Zasshi; 2011 Jan; 100(1):191-8. PubMed ID: 21387654
    [No Abstract]   [Full Text] [Related]  

  • 37. [Non-alcoholic fatty liver disease, as a component of the metabolic syndrome, and its causal correlations with other extrahepatic diseases].
    Halmos T; Suba I
    Orv Hetil; 2017 Dec; 158(52):2051-2061. PubMed ID: 29285942
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Estimated glomerular filtration rate by two equations and their relationship with metabolic syndrome.
    Kawada T
    Clin Chim Acta; 2014 Nov; 437():220-1. PubMed ID: 24785583
    [No Abstract]   [Full Text] [Related]  

  • 39. [Impact of metabolic syndrome on chronic kidney disease].
    Calò LA
    Minerva Med; 2006 Dec; 97(6):451-8. PubMed ID: 17213781
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [ACUTE ATTACK OF RENAL INSUFFICIENCY IN CHRONIC NEPHROPATHY].
    POMPILIAN V; TIEGERMAN T
    Med Interna (Bucur); 1965 Feb; 17():183-90. PubMed ID: 14346201
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.